Detail akcie Eckert & Ziegler online

Business Summary: Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Eckert & Ziegler SE revenues increased 7% to EUR72.9M. Net income applicable to common stockholders increased 7% to EUR10.4M. Revenues reflect Medical segment increase of 21% to EUR41.5M. Net income also reflects Currency gains/losses decrease of 72% to EUR342K (expense), Currency gains increase of 50% to EUR653K (income).